In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K |
Net income | -6.9 | -6.0 | -6.7 | -2.5 | -1.6 | -5.2 | -2.6 | -2.3 |
Depreciation and amortization [+] | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 |
Asset impairment charges | | | | | | | | 1.6 |
Stock-based compensation | 0.8 | 0.3 | 0.4 | 0.0 | 0.4 | | | |
Change in working capital [+] | 0.0 | 1.1 | 1.3 | 0.9 | -0.3 | 1.0 | 0.4 | -1.5 |
Accounts receivable | -1.7 | -0.6 | 1.4 | -1.3 | -1.2 | 0.0 | 0.2 | -0.1 |
Inventories | -1.1 | -0.2 | 0.1 | | | | | |
Accounts payable | 1.2 | 0.4 | -2.0 | | | | | |
Accrued expenses | -0.2 | -0.4 | 0.7 | 0.2 | -0.1 | 0.3 | -0.6 | -0.9 |
Deferred revenues | | | -0.6 | 0.6 | -0.1 | -0.2 | -0.2 | 0.0 |
Other | 1.8 | 1.8 | 1.8 | 1.4 | 1.1 | 1.0 | 1.0 | -0.6 |
Other operating activities | -2.2 | -2.2 | 0.6 | -2.7 | 1.0 | 0.6 | 0.3 | 0.1 |
Cash from operations | -7.9 | -6.6 | -4.2 | -4.0 | -0.3 | -3.6 | -1.8 | -2.1 |
|
Capital expenditures [+] | -0.6 | -0.5 | -0.3 | -0.2 | -0.3 | 0.0 | 0.0 | 0.0 |
Purchases of property and equipment | -0.3 | -0.5 | -0.3 | -0.2 | -0.2 | 0.0 | 0.0 | |
Capitalized product costs | -0.3 | | | | -0.1 | | | |
Purchases of intangible assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
Other cash from investing | | | | | | | | -0.1 |
Cash from investing | -0.6 | -0.6 | -0.3 | -0.2 | -0.3 | 0.0 | 0.0 | -0.1 |
|
Issuance of common stock, net | 10.1 | 4.5 | 9.3 | 0.0 | 0.0 | 5.8 | | |
Other cash from financing | -1.4 | -0.4 | -0.8 | 3.1 | -0.1 | -0.4 | 1.9 | 2.2 |
Cash from financing | 8.7 | 4.1 | 8.4 | 3.1 | -0.1 | 5.4 | 1.9 | 2.2 |
|
Free cash flow | -8.2 | -7.1 | -4.5 | -4.2 | -0.6 | -3.6 | -1.9 | -2.1 |
Per share (diluted) | ($1.38) | ($1.93) | ($1.36) | ($2.37) | ($0.42) | ($1.00) | ($1.00) | ($0.03) |
|
Cash paid for interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 |